Summary The Top 10 R&D Spending Indian Biopharma Companies of 2026 reflect the country’s growing commitment to pharmaceutical innovation, advanced drug develop...
Key Highlights: Implications: By consolidating three injectable-focused entities under one legal umbrella, Aurobindo can streamline manufacturing, R&D, and commercial operati...
Summary: The Top 10 Indian Pharmaceutical Companies of 2026 demonstrate the continued strength and global competitiveness of India’s pharmaceutical sector, led by Sun Pharmaceutical Industries, ...
Key Highlights: Implications: The FTC is allowing Aurobindo’s $250 million Lannett deal only with a divestiture remedy, which should keep competition intact in four generic drug ...
Summary The Top 10 Generic Pharmaceutical Companies of 2025 highlight the continued growth and resilience of the global generics industry, led by Sandoz, Sun Pharma, and Fosun Pharma....
